Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer
Completed · Phase 2 · Has a placebo group
Conditions studied: Cognitive Impairment, Malignant Neoplasm
In brief
This randomized phase II trial studies how well low-dose ibuprofen in improving cognitive impairment in patients with cancer. Anti-inflammatory agents, such as ibuprofen, may slow the decline of cognitive processes and diseases involving the brain.
Key facts
- Study ID
- NCT03186638
- Run by
- University of Rochester NCORP Research Base
- People needed
- 87
- Starts
- 2017-05-26
- Expected to finish
- 2022-06-01
- Last updated by the study team
- 2023-09-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Have a diagnosis of cancer and have had surgery and are now receiving adjuvant or neoadjuvant chemotherapy or who have received chemotherapy within the last 6 months; chemotherapy with concurrent radiation therapy (RT) is allowed
- Answer YES to the question: "Have you noticed any problems in your memory, attention, concentration, multi-tasking or other cognitive functions?" any time after initiation of chemotherapy cycle 1
- NOTE: If a participant answers NO, they may be re-approached at a subsequent cycle
- Be able to swallow medication
- Be able to read English
- Have the ability to understand and to give written informed consent as assessed by the participant's primary care physician or medical oncologist
You may not qualify if…
- Have a confirmed brain tumor or brain metastases
- Be taking a regular daily dose of an NSAID NOTE: Daily doses of 81 mg aspirin are permitted and higher doses of an NSAID on an 'as needed' basis are permitted
- Be diagnosed with dementia or severe neurodegenerative disease
- Have a contraindication to NSAIDs at the oncologist's discretion (i.e., allergy, worsening of ongoing medical problem due to NSAID, very low platelet count from chemotherapy, full-dose anti-coagulation/high risk of bleeding, and uncontrolled conditions such as hypertension, asthma, or peptic ulcer disease)
- Have been hospitalized for treatment of a major psychiatric illness within the last five years
- Have a serum creatinine above 1.5 upper limit of normal (ULN) (collected within the past 4 weeks); ULN is per institutional definition
- Concurrent administration of warfarin, full dose aspirin, clopidogrel, apixaban or other medications known to increase the risk of bleeding or to interfere with antiplatelet activities
- Be colorblind
- Have active substance abuse (e.g. alcohol, drugs) per self-report or medical record
Where it is running
- Beebe Medical Center — Lewes, Delaware, United States
- Delaware Clinical and Laboratory Physicians PA — Newark, Delaware, United States
- Helen F Graham Cancer Center — Newark, Delaware, United States
- Medical Oncology Hematology Consultants PA — Newark, Delaware, United States
- Regional Hematology and Oncology PA — Newark, Delaware, United States
- Christiana Care Health System-Christiana Hospital — Newark, Delaware, United States
- Beebe Health Campus — Rehoboth Beach, Delaware, United States
- Nanticoke Memorial Hospital — Seaford, Delaware, United States
- Christiana Care Health System-Wilmington Hospital — Wilmington, Delaware, United States
- Saint Luke's Mountain States Tumor Institute — Boise, Idaho, United States
- Saint Luke's Mountain States Tumor Institute - Fruitland — Fruitland, Idaho, United States
- Saint Luke's Mountain States Tumor Institute - Meridian — Meridian, Idaho, United States
- Saint Luke's Mountain States Tumor Institute - Nampa — Nampa, Idaho, United States
- Saint Luke's Mountain States Tumor Institute-Twin Falls — Twin Falls, Idaho, United States
- Illinois CancerCare-Bloomington — Bloomington, Illinois, United States
- Illinois CancerCare-Canton — Canton, Illinois, United States
- Memorial Hospital of Carbondale — Carbondale, Illinois, United States
- SIH Cancer Institute — Carterville, Illinois, United States
- Illinois CancerCare-Carthage — Carthage, Illinois, United States
- Centralia Oncology Clinic — Centralia, Illinois, United States
- Cancer Care Specialists of Illinois - Decatur — Decatur, Illinois, United States
- Decatur Memorial Hospital — Decatur, Illinois, United States
- Crossroads Cancer Center — Effingham, Illinois, United States
- Illinois CancerCare-Eureka — Eureka, Illinois, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center — Burbank, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.